120 related articles for article (PubMed ID: 21113600)
1. XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.
Gakis G; Hennenlotter J; Scharpf M; Hevler J; Schilling D; Kuehs U; Stenzl A; Schwentner C
World J Urol; 2011 Dec; 29(6):801-6. PubMed ID: 21113600
[TBL] [Abstract][Full Text] [Related]
2. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
[TBL] [Abstract][Full Text] [Related]
3. XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.
Aufderklamm S; Hennenlotter J; Todenhoefer T; Gakis G; Schilling D; Vogel U; Kuehs U; Dlugosch J; Knapp J; Merseburger A; Gerber V; Ordelheide A; Hevler J; Stenzl A; Schwentner C
World J Urol; 2012 Aug; 30(4):547-52. PubMed ID: 21969130
[TBL] [Abstract][Full Text] [Related]
4. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
5. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
7. Alteration of bone sialoprotein expression in osseous metastasized renal cell carcinomas and the tumor surrounding tissue.
Mittag F; Hennenlotter J; Minkley L; Ipach I; Schilling D; Scharpf M; Stenzl A; Leichtle U; Kluba T
Clin Exp Metastasis; 2012 Feb; 29(2):179-83. PubMed ID: 22130963
[TBL] [Abstract][Full Text] [Related]
8. Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis.
Ramp U; Mahotka C; Heikaus S; Shibata T; Grimm MO; Willers R; Gabbert HE
Histol Histopathol; 2007 Oct; 22(10):1099-107. PubMed ID: 17616937
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma.
Beardo P; Truan Cacho D; Izquierdo L; Alcover-Garcia JB; Alcaraz A; Extramiana J; Mallofré C
Pathol Oncol Res; 2019 Jan; 25(1):289-299. PubMed ID: 29103203
[TBL] [Abstract][Full Text] [Related]
11. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
[TBL] [Abstract][Full Text] [Related]
15. The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.
Luo P; Wang N; He E; Eriksson S; Zhou J; Hu G; Zhang J; Skog S
Pathol Oncol Res; 2010 Jun; 16(2):277-83. PubMed ID: 19957115
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.
Rausch S; Beermann J; Scharpf M; Hennenlotter J; Fend F; Stenzl A; Schollenberger D; Bedke J; Kruck S
World J Urol; 2016 Dec; 34(12):1635-1641. PubMed ID: 26995391
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features.
Zheng W; Goodman AL; Velázquez Vega JE; Yin F; Fung KM; Osunkoya AO
Appl Immunohistochem Mol Morphol; 2020; 28(5):395-402. PubMed ID: 30882396
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
[TBL] [Abstract][Full Text] [Related]
20. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
